The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Randomized phase III trial of aumolertinib (HS-10296, Au) versus gefitinib (G) as first-line treatment of patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) and EGFR exon 19 del or L858R mutations (EGFRm).
 
Shun Lu
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; GenomiCare; Hutchison MediPharma; Menarini; Pfizer; PrIME Oncology; Roche; Simcere; Yuhan; Zai Lab
Speakers' Bureau - AstraZeneca; Hansoh; Hengrui Therapeutics; Roche
Research Funding - AstraZeneca; BMS; Hansoh; HenRui; Hutchison MediPharma; Roche
 
Xiaorong Dong
No Relationships to Disclose
 
Hong Jian
No Relationships to Disclose
 
Jianhua Chen
No Relationships to Disclose
 
Gongyan Chen
No Relationships to Disclose
 
Yuping Sun
No Relationships to Disclose
 
Yinghua Ji
No Relationships to Disclose
 
Ziping Wang
Consulting or Advisory Role - Hansoh Pharma
Research Funding - Hansoh Pharma (Inst)
 
Jianhua Shi
Consulting or Advisory Role - Hansoh Pharma
Research Funding - Hansoh Pharma (Inst)
 
JunGuo Lu
No Relationships to Disclose
 
Shaoshui Chen
Consulting or Advisory Role - Hansoh Pharma
Research Funding - Hansoh Pharma (Inst)
 
Guojun Zhang
Consulting or Advisory Role - Hansoh Pharma
Research Funding - Hansoh Pharma (Inst)
 
Dongqing Lv
No Relationships to Disclose
 
Chunling Liu
No Relationships to Disclose
 
Juan Li
No Relationships to Disclose
 
Xinmin Yu
No Relationships to Disclose
 
Zhong Lin
No Relationships to Disclose
 
Zhuang Yu
No Relationships to Disclose
 
Zhehai Wang
Consulting or Advisory Role - Hansoh Pharma
Research Funding - Hansoh Pharma (Inst)
 
Jiuwei Cui
No Relationships to Disclose